Firefly Neuroscience (AIFF) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$0.2.

  • Firefly Neuroscience's EPS (Weighted Average and Diluted) rose 6721.31% to -$0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.03, marking a year-over-year increase of 550.46%. This contributed to the annual value of -$0.09 for FY2021, which is 36228.6% down from last year.
  • Per Firefly Neuroscience's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.2 for Q3 2025, which was up 6721.31% from -$0.61 recorded in Q3 2024.
  • Firefly Neuroscience's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.36 during Q2 2023, with a 5-year trough of -$1.88 in Q2 2024.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.11 (2021), whereas its average is -$0.26.
  • In the last 5 years, Firefly Neuroscience's EPS (Weighted Average and Diluted) tumbled by 255331.05% in 2022 and then surged by 53063.87% in 2023.
  • Over the past 5 years, Firefly Neuroscience's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.11 in 2021, then plummeted by 138.19% to -$0.26 in 2022, then surged by 240.78% to $0.36 in 2023, then crashed by 269.44% to -$0.61 in 2024, then surged by 67.21% to -$0.2 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.2 for Q3 2025, versus -$0.61 for Q3 2024 and -$1.88 for Q2 2024.